Riskpilot← Back to searchSign inGet full accessTM-Medica Oy
OYDissolvedY-tunnus 2991343-6Oikokatu 1-E34Medical specialists activities · NACE 8622Est. 2019— employees
Revenue 2025
EUR 434K
-4% vs 2024
EBITDA margin
65.9%
-1% vs 2024
Equity ratio
48.7%
Financial strength
Net profit 2025
EUR 231K
-1% vs 2024
| Revenue | EUR 434K | -4% |
| EBITDA | EUR 286K | -1% |
| Net profit | EUR 231K | -1% |
| Total assets | EUR 481K | +89% |
| Equity | EUR 234K | +0% |
| Employees | — | — |
Legal name
TM-Medica Oy
Y-tunnus number
2991343-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
25. maaliskuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Lääkäripalvelujen tuottaminen potilaille, alan koulutus-ja konsultointipalvelujen tuottaminen sekä luennointi. Yhtiö voi tuottaa lehtiartikkeleita ja asiantuntijalausuntoja. Yhtiö voi omistaa, hallita ja vuokrata sekä välittää kiinteistöjä, liike-ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Oikokatu 1-E34
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 405 | 361 | 452 | 452 | 434 |
| Staff expenses | −65 | −66 | −66 | −66 | −65 |
| EBITDA | 263 | 211 | 271 | 288 | 286 |
| Depreciation & amort. | −1 | −3 | −0 | −0 | −0 |
| EBIT | 262 | 208 | 270 | 288 | 286 |
| Net financials | 0 | 4 | −2 | 2 | 0 |
| Profit before tax | 262 | 212 | 268 | 290 | 288 |
| Tax | 53 | 43 | 54 | 58 | −57 |
| Net profit | 209 | 169 | 214 | 232 | 231 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 488 | 595 | 764 | 254 | 481 |
| Equity | 459 | 591 | 218 | 235 | 234 |
| Long-term debt | — | — | 0 | 0 | — |
| Short-term debt | 30 | 4 | 546 | 19 | 247 |
| Total debt | 30 | 4 | 546 | 19 | 247 |
EBITDA margin
65.9%
This company
15.8%
Market median
+317% vs market
20212025
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
98.6%
This company
18.4%
Market median
+436% vs market
20212025
Net profit margin
53.2%
This company
8.1%
Market median
+557% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
SE Deputy Member | Deputy Member | 2019 |
TM Chief Executive Officer | Chief Executive Officer | 2019 |
JA | Audit | 2019 |
PR Deputy auditor | Deputy auditor | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TM-Medica Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sami Edvard Kiiskinen | Deputy Member | 0 companies |
| Terhi Maria Modenius | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |